數字王國(00547.HK)擬發行約6.46億股 淨籌約1.43億港元
格隆匯4月20日丨數字王國(00547.HK)公吿,於2023年4月20日,公司訂立認購協議,內容有關發行及認購新認購股份。待認購協議的先決條件獲達成後,公司同意發行,而認購人同意認購6.46億股認購股份,認購價為每股認購股份0.222港元。認購股份總數佔經發行認購股份擴大後的股份總數約12.44%(假設自公吿日期起至完成日期止,股份總數將並無其他變動)。
發行認購股份的所得款項淨額(扣除相關開支後)將約為1.43億港元。集團擬將所得款項淨額約1.2億港元用於發展集團的媒體娛樂分部,餘下約2310萬港元用於集團的一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.